A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index

Biotech 100 Requirements




The Biotech-100 Index includes 100 small cap biotechnology stocks whose product pipeline contain at least one drug in either phase II and/or Phase III clinical development.

There is a 90% chance of rejection in early-stage phase I trials;

a 50% chance in phase II;

20% in phase III;

and 10% post-phase III are rough guidelines.

Companies that are in phase II and III tend to show great promise but still have a high degree of volatiliy.

See the Biotech100 List



Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?
Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?
Key Biotech Terms





Copyright 2005 All rights reserved